Chemours
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,501,000 | $1,538,000 | $1,350,000 | $1,361,000 |
Gross Profit | 286,000 | 307,000 | 286,000 | 244,000 |
EBITDA | 117,000 | 216,000 | 186,000 | 52,000 |
EBIT | 39,000 | 142,000 | 115,000 | -22,000 |
Net Income | -27,000 | 70,000 | 52,000 | -26,000 |
Net Change In Cash | 1,501,000 | 1,538,000 | 1,350,000 | 1,361,000 |
Free Cash Flow | 63,000 | -693,000 | -392,000 | 349,000 |
Cash | 596,000 | 619,000 | 746,000 | 1,807,000 |
Basic Shares | 149,697 | 150,123 | 150,050 | 148,587 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $6,027,000 | $6,794,000 | $6,345,000 | $4,969,000 |
Gross Profit | 1,306,000 | 1,616,000 | 1,381,000 | 1,067,000 |
EBITDA | 197,000 | 1,204,000 | 1,205,000 | 767,000 |
EBIT | -110,000 | 913,000 | 888,000 | 447,000 |
Net Income | -238,000 | 578,000 | 608,000 | 219,000 |
Net Change In Cash | 6,027,000 | 6,794,000 | 6,345,000 | 4,969,000 |
Cost of Revenue | -215,000 | 480,000 | 124,000 | |
Free Cash Flow | 186,000 | 447,000 | 543,000 | 540,000 |
Cash | 1,203,000 | 1,102,000 | 1,451,000 | 1,105,000 |
Basic Shares | 148,912 | 158,303 | 168,698 | 166,346 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.40 |
2024-06-30 | $0.38 |
2024-03-31 | $0.32 |
2023-12-31 | $0.31 |
